Kura Oncology to Lead Investor Engagement at Three Major Events What’s Happening? Kura Oncology, a Nasdaq-listed biopharmaceutical company, is set to participate in three major investor...
Breakthrough Breast Cancer Research Halted by Funding Cut What’s Happening? The U.S. government has abruptly canceled nearly $500 million in contracts for mRNA vaccine research, putting...
